Impelsys Launches an Advanced Medical Device Testing Facility

The facility was inaugurated by
Impelsys prides itself on being an organization that anticipates the needs of its clients and changing trends. With technology becoming a key differentiator in providing quality healthcare, the medical device testing facility is designed to make diagnostics and patient care safer.
Impelsys offers comprehensive Quality Engineering services leveraging the latest automation tools covering functional and non-functional testing. The QA team works closely with customers from all over the world to help them deliver high-quality, flawless, products and solutions.
About Impelsys
Impelsys is a leading provider of digital transformation solutions that empower organizations across the globe to become digital-first, data-driven intelligent enterprises. With over two decades of expertise in innovation and technology, Impelsys is a trusted partner for organizations seeking end-to-end digital advancement.
*Impelsys has been a long-term partner of Laerdal, a world leader in healthcare education and resuscitation training, focused on improving healthcare quality.
Press Desk Contact
[email protected]
+91-9686629989
Impelsys Pvt. Ltd
Photo: https://mma.prnewswire.com/media/2304145/Vincent_Emerald_Shyam_Shetty.jpg
Logo: https://mma.prnewswire.com/media/2304235/Impelsys_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/impelsys-launches-an-advanced-medical-device-testing-facility-302019169.html
SOURCE Impelsys
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PwC US and PwC India Form Joint Venture to Help Clients Grow and Compete at Greater Speed and Scale
- Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
- Apeing Opens Stage 3 of $APEING Presale at $0.0004 as Project Advances Its 33-Stage Token Sale
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share